Thrombosis in Diabetes and Its Clinical Management

Amy L. Cilia La Corte, Helen Philippou, Robert A.S. Ariëns, Role of Fibrin Structure in Thrombosis and Vascular Disease Advances in Protein Chemistry. ,vol. 83, pp. 75- 127 ,(2011) , 10.1016/B978-0-12-381262-9.00003-3

Salim Yusuf, Shamir R Mehta, Susan Chrolavicius, Janine Pogue, Christopher B Granger, Andrzej Budaj, Ron JG Peters, Jean-Pierre Bassand, Lars Wallentin, Campbell Joyner, Keith AA Fox, None, Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial JAMA. ,vol. 295, pp. 1519- 1530 ,(2006) , 10.1001/JAMA.295.13.JOC60038

Bernhard Witzenbichler, Roxana Mehran, Giulio Guagliumi, Dariusz Dudek, Kurt Huber, Ran Kornowski, Thomas D. Stuckey, Martin Fahy, Helen Parise, Gregg W. Stone, Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. Jacc-cardiovascular Interventions. ,vol. 4, pp. 760- 768 ,(2011) , 10.1016/J.JCIN.2011.04.008

David J. Schneider, Anti-platelet therapy: glycoprotein IIb-IIIa antagonists. British Journal of Clinical Pharmacology. ,vol. 72, pp. 672- 682 ,(2011) , 10.1111/J.1365-2125.2010.03879.X

Ronan Roussel, Florence Travert, Blandine Pasquet, Peter WF Wilson, Sidney C Smith, Shinya Goto, Philippe Ravaud, Michel Marre, Avi Porath, Deepak L Bhatt, P Gabriel Steg, Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators, None, Metformin Use and Mortality Among Patients With Diabetes and Atherothrombosis JAMA Internal Medicine. ,vol. 170, pp. 1892- 1899 ,(2010) , 10.1001/ARCHINTERNMED.2010.409

V. SCHROEDER, A. M. CARTER, J. DUNNE, M. W. MANSFIELD, P. J. GRANT, Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes. Journal of Thrombosis and Haemostasis. ,vol. 8, pp. 2080- 2082 ,(2010) , 10.1111/J.1538-7836.2010.03966.X

Pedro R. Moreno, Alvaro M. Murcia, Igor F. Palacios, Miltiadis N. Leon, Victor H. Bernardi, Valentín Fuster, John T. Fallon, Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus Circulation. ,vol. 102, pp. 2180- 2184 ,(2000) , 10.1161/01.CIR.102.18.2180

José Luis Ferreiro, Ángel R Cequier, Dominick J Angiolillo, Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease. Diabetes and Vascular Disease Research. ,vol. 7, pp. 274- 288 ,(2010) , 10.1177/1479164110383995

D LI, K CHEN, N SINHA, X ZHANG, Y WANG, A SINHA, F ROMEO, J MEHTA, The effects of PPAR-γ ligand pioglitazone on platelet aggregation and arterial thrombus formation Cardiovascular Research. ,vol. 65, pp. 907- 912 ,(2005) , 10.1016/J.CARDIORES.2004.11.027

I-Chih Chen, Ting-Hsing Chao, Wei-Chuan Tsai, Yi-Heng Li, Rosiglitazone reduces plasma levels of inflammatory and hemostatic biomarkers and improves global endothelial function in habitual heavy smokers without diabetes mellitus or metabolic syndrome. Journal of the Formosan Medical Association. ,vol. 109, pp. 113- 119 ,(2010) , 10.1016/S0929-6646(10)60031-9